CyberKnife prostate cancer treatments

Prostate Cancer

Prostate cancer is the second most common cancer in men worldwide and is one of the more recent additions to the CyberKnife® treatment repertoire. It is currently being used as monotherapy treatment for early stage prostate cancer or as a boost following conventional radiation therapy.

For more information on treatments for prostate cancer we suggest that you visit the prostate cancer page of the CyberKnife manufacturer's web site. As protocols are developed and extended Accuray Inc update their materials accordingly. You can be sure of finding the latest published information on this area of treatment, though you cannot apply for treatment there.

CyberKnife Centres

Once you have considered Accuray's general information on prostate cancer you can make a treatment enquiry through this web site. We are currently able to pass prostate cancer cases for assessment to the following centres:

Advanced treatment centres

Non-invasive medical technologies

Private medical centres

Other useful links for prostate cancer

Please visit the prostate section of the Links Page

CyberKnife can reproduce the conformality for organ coverage achievable with brachytherapy and local control and complication rates are expected to be similar to HDR (high dose rate) brachytherapy. CyberKnife centres may vary in their approach but as a general guideline up to stage 2a tumours, PSA under 10 ng/dl and a negative Cholin PET CT for body metastases.

More information

Individual CyberKnife centres may adopt slightly different approaches to which cases they will treat and how they will treat them, including how many treatment sessions are required.

Visit Accuray Inc. prostate cancer page

European CyberKnife Centre, Munich (selected cases only) HCG (Healthcare Global), Bangalore

Iatropolis CyberKnife Centre, Athens Radiotherapie Hirslanden, Zurich

MHL

cyberknifeservice.com

Healthcare for the
Internet Age

MHL international web sites

MHL web sites in 28 countries